Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2024-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) including an agenda for the election of directors and approval of financial statements. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2024-03-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a '주주총회소집공고' (Notice of General Meeting of Shareholders) which includes a '정정신고' (Correction Report) regarding the agenda items for the upcoming Annual General Meeting. It contains detailed information about the meeting date, location, agenda items (including director appointments), and management reference materials (경영참고사항). This document is a formal proxy statement/notice sent to shareholders to inform them of the meeting and solicit their participation/votes. In the provided taxonomy, this fits best under 'Proxy Solicitation & Information Statement' (PSI).
2024-03-14 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '정정신고' (Correction Report) for an '의결권대리행사권유참고서류' (Proxy Solicitation & Information Statement). It details changes to the list of director candidates for an upcoming Annual General Meeting (AGM). This document is a formal proxy solicitation material used to request shareholder votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의), which includes the date, location, agenda items (financial statement approval, director appointments, and compensation limits), and details regarding electronic voting. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-02-27 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) for HLB Life Science Co., Ltd. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic proxy/voting), and agenda items such as the approval of financial statements and director compensation. This document is a formal proxy solicitation material sent to shareholders to request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-02-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for HLB Life Science. It contains the meeting agenda, date, location, voting procedures, and detailed management reference materials (business overview, board activities, and financial transaction details) required by Korean commercial law for such notices. This document is the official proxy statement/notice package provided to shareholders to inform them of the upcoming meeting and solicit their participation/votes.
2024-02-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.